MetaCap

Edgewise Therapeutics Insider Trades

NASDAQ: EWTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

39.06-0.17 (-0.43%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $199.40K
Sales
33 · $19.50M
Shares bought / sold
10.70K / 580.49K
Net activity
Net selling $19.3 million

Edgewise Therapeutics insider activity

Over the last 12 months, Edgewise Therapeutics insiders reported 59 transactions on SEC Form 4: 1 open-market purchase and 33 sales. Insiders bought $199,403 and sold $19.5 million worth of stock, for net insider selling of $19.3 million. The largest seller was Russell Alan J, with $10.3 million in reported sales.

The most recent filing shows Fox Jonathan C (Director) reporting a transaction in 308 shares on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put EWTX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

EWTX insider transactions

Edgewise Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Oct 1, 2026Fox Jonathan CDirectorAward308—Form 4
Aug 13, 2026Donovan Joanne M.CMOSale2,919$126.70KForm 4
Aug 12, 2026Derakhshan BehradChief Business OfficerSale2,475$108.15KForm 4
Aug 12, 2026Derakhshan BehradChief Business OfficerSale150$6.67KForm 4
Aug 12, 2026Derakhshan BehradChief Business OfficerSale304$13.53KForm 4
Aug 12, 2026Derakhshan BehradChief Business OfficerSale2,171$95.08KForm 4
Aug 12, 2026Derakhshan BehradChief Business OfficerOption exercise7,500—Form 4
Aug 12, 2026Derakhshan BehradChief Business OfficerOption exercise5,781—Form 4
Aug 12, 2026MOORE JOHN RGeneral CounselSale2,419$105.95KForm 4
Aug 12, 2026MOORE JOHN RGeneral CounselSale99$4.41KForm 4
Aug 12, 2026MOORE JOHN RGeneral CounselSale59$2.62KForm 4
Aug 12, 2026MOORE JOHN RGeneral CounselSale2,439$106.85KForm 4
Aug 12, 2026MOORE JOHN RGeneral CounselOption exercise6,718—Form 4
Aug 12, 2026MOORE JOHN RGeneral CounselOption exercise5,781—Form 4
Aug 12, 2026Russell Alan JChief Scientific OfficerSale390$17.34KForm 4
Aug 12, 2026Russell Alan JChief Scientific OfficerSale2,273$99.28KForm 4
Aug 12, 2026Russell Alan JChief Scientific OfficerSale3,238$141.43KForm 4
Aug 12, 2026Russell Alan JChief Scientific OfficerOption exercise7,031—Form 4
Aug 12, 2026Russell Alan JChief Scientific OfficerOption exercise5,781—Form 4
Aug 12, 2026KOCH KEVINPresident and CEOSale913$40.47KForm 4
Aug 12, 2026KOCH KEVINPresident and CEOSale8,276$361.32KForm 4
Aug 12, 2026KOCH KEVINPresident and CEOSale8,782$383.25KForm 4
Aug 12, 2026KOCH KEVINPresident and CEOOption exercise21,875—Form 4
Aug 12, 2026KOCH KEVINPresident and CEOOption exercise17,969—Form 4
Aug 12, 2026Donovan Joanne M.CMOSale800$35.61KForm 4
Aug 12, 2026Donovan Joanne M.CMOSale104$4.62KForm 4
Aug 12, 2026Donovan Joanne M.CMOSale2,779$121.46KForm 4
Aug 12, 2026Donovan Joanne M.CMOSale2,839$124.30KForm 4
Aug 12, 2026Donovan Joanne M.CMOOption exercise7,031—Form 4
Aug 12, 2026Donovan Joanne M.CMOOption exercise5,781—Form 4
Jul 1, 2026Fox Jonathan CDirectorAward319—Form 4
Jul 1, 2026Russell Alan JChief Scientific OfficerSale69,648$2.74MForm 4
Jul 1, 2026Russell Alan JChief Scientific OfficerSale130,352$5.14MForm 4
Jul 1, 2026Russell Alan JChief Scientific OfficerOption exercise69,648$12.54KForm 4
Jul 1, 2026Russell Alan JChief Scientific OfficerOption exercise130,352$58.66KForm 4
May 5, 2026Donovan Joanne M.CMOSale50,000$1.93MForm 4
May 5, 2026Donovan Joanne M.CMOOption exercise50,000$354.00KForm 4
May 4, 2026Donovan Joanne M.CMOSale5,230$163.66KForm 4
Apr 1, 2026Donovan Joanne M.CMOSale28,662$926.10KForm 4
Apr 1, 2026Donovan Joanne M.CMOOption exercise28,662$202.93KForm 4
Apr 1, 2026Fox Jonathan CDirectorAward339—Form 4
Mar 31, 2026Donovan Joanne M.CMOSale21,338$685.31KForm 4
Mar 31, 2026Donovan Joanne M.CMOOption exercise21,338$151.07KForm 4
Mar 27, 2026Donovan Joanne M.CMOSale6,735$208.64KForm 4
Mar 27, 2026Donovan Joanne M.CMOSale9,623$298.10KForm 4
Jan 21, 2026Edris BadreddinDirectorSale66,477$1.96MForm 4
Jan 21, 2026Edris BadreddinDirectorSale10,463$308.03KForm 4
Jan 21, 2026Edris BadreddinDirectorSale7,605$223.89KForm 4
Jan 21, 2026Edris BadreddinDirectorSale17,236$507.43KForm 4
Jan 21, 2026Edris BadreddinDirectorSale13,690$403.03KForm 4
Jan 21, 2026Edris BadreddinDirectorOption exercise7,605$5.40KForm 4
Jan 21, 2026Edris BadreddinDirectorOption exercise66,477$128.30KForm 4
Jan 21, 2026Edris BadreddinDirectorOption exercise10,463$20.19KForm 4
Jan 21, 2026Edris BadreddinDirectorOption exercise17,236$11.03KForm 4
Jan 21, 2026Edris BadreddinDirectorOption exercise13,690$5.34KForm 4
Jan 2, 2026Fox Jonathan CDirectorAward473—Form 4
Nov 12, 2025Russell Alan JChief Scientific OfficerSale100,000$2.11MForm 4
Nov 12, 2025Russell Alan JChief Scientific OfficerOption exercise100,000$18.00KForm 4
Nov 11, 2025Fox Jonathan CDirectorBuy10,700$199.40KForm 4
Oct 1, 2025Fox Jonathan CDirectorAward728—Form 4
Aug 26, 2025Russell Alan JChief Scientific OfficerSale100,000$1.46MForm 4
Aug 26, 2025Russell Alan JChief Scientific OfficerOption exercise100,000$18.00KForm 4
Aug 12, 2025KOCH KEVINPresident and CEOSale7,972$106.76KForm 4
Aug 12, 2025KOCH KEVINPresident and CEOOption exercise17,968—Form 4
Aug 12, 2025Russell Alan JChief Scientific OfficerSale1,907$25.54KForm 4
Aug 12, 2025Russell Alan JChief Scientific OfficerOption exercise5,781—Form 4
Aug 12, 2025Carruthers R MichaelChief Financial OfficerSale1,428$19.12KForm 4
Aug 12, 2025Carruthers R MichaelChief Financial OfficerOption exercise5,781—Form 4
Aug 12, 2025Derakhshan BehradChief Business OfficerSale2,491$33.36KForm 4
Aug 12, 2025Derakhshan BehradChief Business OfficerOption exercise5,781—Form 4
Aug 12, 2025MOORE JOHN RGeneral CounselSale2,098$28.10KForm 4
Aug 12, 2025MOORE JOHN RGeneral CounselOption exercise5,781—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related